Health topic


Reveal the impact of antiresorptive
treatment in just 3 months.

Gaining efficacy results in just 3 months will increase the likelihood your patient remains compliant with therapy—which will increase her chances of avoiding a dreaded fracture.

With a menu of highly specific bone marker assays—such as the Elecsys β-CrossLaps—that determine how well her osteoporosis medications are working, there’s no longer a need to wait 2 years for your patient’s next DXA scan.

Find out how Roche can help you assure her and safeguard her compliance. Call (800) 428-2336 (select option 2).
Learn more


1. Facts about Bone Health. National Osteoporosis Foundation Web site. Accessed April 21, 2021. 

2. What is osteoporosis? National Osteoporosis Foundation Web site. Accessed November 20, 2018. 

3. Warriner AH, Curtis JR. Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol. 2009;21(4):356-362. 

4. Bonnick SL, Shulman L. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med. 2006;119(4A):25S-31S.

*Due to osteoporosis; in women over age 50.

Found 0 results in